Vor Biopharma annual return on equity
2021
2022
2023
2024
Vor Biopharma Return on Equity (ROE) Growth & History (VOR)
Vor Biopharma's return on equity was −432.53% for fiscal 2024.
View full Vor Biopharma company overviewVor Biopharma annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2024 | 2024-12-31 | −432.53% | −373.80 pp |
| 2023 | 2023-12-31 | −58.74% | −19.28 pp |
| 2022 | 2022-12-31 | −39.45% | +48.21 pp |
| 2021 | 2021-12-31 | −87.66% | — |
Vor Biopharma quarterly return on equity
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q3 2024 | 2024-09-30 | −32.23% | −14.72 pp |
| Q2 2024 | 2024-06-30 | −25.18% | −11.39 pp |
| Q1 2024 | 2024-03-31 | −22.50% | −10.68 pp |
| Q4 2023 | 2023-12-31 | −16.14% | −4.45 pp |
| Q3 2023 | 2023-09-30 | −17.50% | −3.25 pp |
| Q2 2023 | 2023-06-30 | −13.79% | −2.07 pp |
| Q1 2023 | 2023-03-31 | −11.83% | −0.75 pp |
| Q4 2022 | 2022-12-31 | −11.68% | −3.56 pp |
| Q3 2022 | 2022-09-30 | −14.26% | −6.57 pp |
| Q2 2022 | 2022-06-30 | −11.73% | −4.62 pp |
| Q1 2022 | 2022-03-31 | −11.07% | +2.12 pp |
| Q4 2021 | 2021-12-31 | −8.13% | — |
| Q3 2021 | 2021-09-30 | −7.68% | — |
| Q2 2021 | 2021-06-30 | −7.10% | — |
| Q1 2021 | 2021-03-31 | −13.19% | — |
Vor Biopharma return on equity trends
Between the periods ended 2021-12-31 and 2024-12-31, Vor Biopharma's return on equity decreased from −87.66% to −432.53%, a change of −344.88 percentage points. The latest reported quarter, Q3 2024, shows −32.23%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Vor Biopharma source filings ↗